GALT - Galectin Therapeutics GAAP EPS of -$0.74
2024-03-29 08:33:36 ET
More on Galectin Therapeutics
- Galectin: Q4 2024 NASH Cirrhosis Data Readout Is A Major Inflection Point
- Seeking Alpha’s Quant Rating on Galectin Therapeutics
- Historical earnings data for Galectin Therapeutics
- Financial information for Galectin Therapeutics